Head to Head Review: Disaboom (OTCMKTS:MEDH) vs. Elekta (OTCMKTS:EKTAY)

Elekta (OTCMKTS:EKTAY) and Disaboom (OTCMKTS:MEDH) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, risk, profitability, valuation and institutional ownership.

Valuation and Earnings

This table compares Elekta and Disaboom”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Elekta	$1.71 billion	1.34	$22.37 million	$0.07	88.43
Disaboom	$890,000.00	0.47	-$170,000.00	N/A	N/A

Elekta has higher revenue and earnings than Disaboom.

Analyst Recommendations

This is a breakdown of recent ratings and price targets for Elekta and Disaboom, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Elekta	1	2	0	0	1.67
Disaboom	0	0	0	0	0.00

Profitability

This table compares Elekta and Disaboom’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Elekta	1.62%	12.14%	3.79%
Disaboom	5.91%	N/A	N/A

Risk & Volatility

Elekta has a beta of 1.06, meaning that its share price is 6% more volatile than the S&P 500. Comparatively, Disaboom has a beta of 1.68, meaning that its share price is 68% more volatile than the S&P 500.

Summary

Elekta beats Disaboom on 6 of the 8 factors compared between the two stocks.

About Elekta

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services. It also provides Elekta Studio, an image guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Venezia applicator that enables the oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; Geneva, an applicator for cervical cancer treatment; veterinary radiation therapy products; and Elekta Kaiku for personalized cancer care. In addition, the company offers stereotactic radiosurgery, such as Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for radiosurgeons; and Elekta Esprit. Further, it provides neurosurgery products comprising Leksell Vantage Stereotactic System for intracranial neurosurgery; and Leksell Stereotactic System for minimally invasive stereotactic neurosurgery. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.

About Disaboom

Dazed, Inc. focuses on retail, distribution, hospitality, licensing, and franchising of portfolio of counterculture brands. The company was formerly known as MedX Holdings, Inc. and changed its name to Dazed, Inc. in October 2022. Dazed, Inc. was founded in 2004 and is based in Cheyenne, Wyoming.